baber/WOPTO huggingface dataset:
Patent NZ-197960-A (NZ)
Title: Cutting insert for metal working tool
Inventor: WARREN D W
IPC: B23B27/16
Filed: 1981-08-07
Abstract: A cutting insert with indexable cutting edges with a chip-breaker configuration which comprises discrete recesses spaced along the length of the cutting insert. The cutting insert has a descending wall that joins the cutting edge or the land behind the cutting edge with a planar floor that extends toward the center of the insert. The recesses are formed in the descending wall adjacent the cutting edge or land behind the cutting edge and are concave facing outwardly as they extend inwardly of the insert. The inserts are coated, preferably with a TiN over TiC chemical vapor deposition coating.
Patent NZ-198142-A (NZ)
Title: Combustible block:gelled fuel and perlite
Inventor: FOX R T
IPC: C10L5/40
Filed: 1981-08-24
Abstract: A combustible composition comprising a fuel in the form of a wax, gel or paste having expanded perlite dispersed therein serving to decrease the rate at which the fuel burns on combustion of the composition and optionally a combustible filler material, the composition being such that it does not flow substantially during combustion.
Patent NZ-209483-A (NZ)
Title: Compressed absorbent aggregate; superabsorbent material with hydrophilic filler
Inventor: PIENIAK H A
IPC: A61F13/20
Filed: 1984-09-07
Abstract: The invention provides a compressed aggregate of superabsorbent and a filler. The aggregate is in the form of tablets or granules and absorbs liquid rapidly. The aggregate may be used in disposable absorbent products, such as diapers, tampons and sanitary napkins, and in containers such as colostomy bags, urinary bags, bedpans and the like.
Patent NZ-210082-A (NZ)
Title: Bakery products: include microporous whole grains
Inventor: GREETHEAD G F
IPC: A21D2/36
Filed: 1984-11-02
Abstract: Wholegrain bakery products such as bread or biscuits which incorporate whole grains of cereal such as wheat or rye are made by using heat-treated microporous grain. This avoids extensive pre-soaking required for hydrating natural untreated grain.
Patent NZ-218413-A (NZ)
Title: Dil ic packaging with distinct conductive and transparent portions
Inventor: WEI HSIUNG YEN
IPC: B65D81/02
Filed: 1986-11-26
Abstract: A container for loosely housing dual-in-line components 4 comprises an elongate tubular member 1. The tubular member is substantially U-shaped in cross-section and includes a hollow central portion 2 for receiving the body of the components, and flanking portions 3 for receiving the legs 5 of the components. The tubular member is so shaped that the components can only touch the tubular member in certain predetermined locations 8, 9, 10, and to protect the components from static discharges on contacting the container, only these locations need be made conductive, the remainder of the container being of transparent plastic. In one embodiment the container may be provided with conducting ribs (13) on the outside so that when two such containers come into contact it is not possible for two non-conducting parts to come into contact so generating static.
Patent NZ-218578-A (NZ)
Title: N,n-dimethyl-1-(1-(4-chlorophenyl)cyclobutyl)-3-methyl butylamine hydrochloride monohydrate and pharmaceutical compositions
Inventor: JEFFERY J E
IPC: C07C211/33
Filed: 1986-12-10
Abstract: N,N-Dimethyl-1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutylamine hydrochloride monohydrate is a non-hygroscopic material which can be used as a pharmaceutical in the treatment of depression.
Patent NZ-227788-A (NZ)
Title: Peptide having growth hormone regulatory effects, and compositions
Inventor: BOWERS CYRIL YARLING
IPC: C07K17/08
Filed: 1989-01-30
Abstract: Disclosed are novel polypeptide compounds which promote the release and elevation of growth hormone levels in the blood of animals. Also disclosed are methods of promoting the release and elevation of growth hormone levels in the blood of animals using the disclosed polypeptide compounds.
Patent NZ-236198-A (NZ)
Title: Dental amalgam capsule: alloy mixed and dispensed therefrom
Inventor: CHEETHAM JEFFERY JAMES
IPC: A61C5/06
Filed: 1990-11-23
Abstract: The invention relates to a dental amalgam capsule 10 arranged to contain mercury in a first compartment 16 and dental alloy powder in a second, or mixing, compartment 18, a conduit 28 being provided so that amalgam can be dispensed by a rod 66 directly from the capsule 10 into a cavity in a tooth.
Patent NZ-247951-A (NZ)
Title: Rotary mower with pressurised air circuit for collection of cuttings
Inventor: BOWDEN MICHAEL
IPC: A01D34/63
Filed: 1993-06-22
Abstract: In more detail the machine comprises a housing (1) including a cutting chamber (3) opening towards ground datum (GD), a grass cutter (5) mounted in the cutting chamber (3), a power source (7), a drive line (6) drivingly connecting the power source (7) and the grass cutter (5), a removable grass collector (GB), access means (10) affording access between the cutting chamber (3) and the grass collector (GB), at least one fan (8) for producing a stream of pressurised air, means for directing the pressurised air into the cutting chamber (3) for conveying grass cuttings from the cutting chamber (3) through the access means (10) into the grass collector (GB), a filter (F) for retaining the grass cuttings in the grass collector (GB) and ducting for directing the so filtered air to the fan (8) for recirculation. <IMAGE>
Patent NZ-248140-A (NZ)
Title: Large dimension emulsion polymer particle, high aspect ratio emulsion polymer particles (optionally crosslinked), high aspect ratio carbon particles and coating compositions
Inventor: CHIOU SHIANG-JAW
IPC: C08J5/00
Filed: 1993-07-13
Abstract: A process for preparing large dimension emulsion polymer particles and the polymer products of the process are disclosed. In one embodiment, the invention provides particles having a high aspect ratio, having a shape described by a long axis and an intersecting short axis. These particles range in shape from egg-like, through rod-like, up to extended filaments. In another embodiment, the invention relates to large, nearly spherical emulsion polymer particles. <IMAGE>
Patent NZ-281879-A (NZ)
Title: Packaging machine hold-down rails for cartons during filling being vertically and laterally adjustable
Inventor: LIANG KUN
IPC: B65B59/00
Filed: 1995-02-28
Abstract: A selectively adjustable apparatus permits the holding down and stabilizing of cartons in a continuous motion packaging machine as grouped articles are inserted into the cartons. The apparatus includes a pair of spaced parallel hold-down rails (56, 62) adapted to engage the tops of moving cartons with light force to hold the cartons down and inhibit their deformation as grouped articles are inserted with significant momentum into the cartons. A side rail (97) is provided and positioned to engage the back ends of the moving cartons to absorb the momentum of grouped articles as the articles are inserted into the cartons. A system of vertical and horizontal guide rails (38, 39, 46, 47, 57, 58), sliding guide blocks (41, 42, 48, 49, 63, 64), brackets (43, 44, 51, 52, 66, 67), and actuators (32, 73, 74) provides for rapid and accurate adjustment of the vertical positions and spacing of the hold-down rails and the transverse position of the side rail and rear hold-down rail to accommodate cartons of virtually any size. Thus, the apparatus can be reconfigured quickly, accurately, and reliably to accommodate a change in carton size necessitated by a change in article size or article group configuration without breakdown and without the resources of a trained technician.
Patent NZ-285283-A (NZ)
Title: Child resistant bottle closure - push tab depressed to disengage closure tooth from locking surface of a cantilevered beam on bottle neck finish
Inventor: THOMAS JOHN HALL
IPC: B65D41/04
Filed: 1995-05-03
Abstract: A package suitable for storing and dispensing potentially dangerous material, which is resistant to opening by children yet readily openable by adults. The package is preferably a bottle which has a body and a finish portion. The finish portion has a threaded outer end for mating with a closure. A resiliently deformable cantilevered beam is connected to the finish portion between the threaded outer end and the body of the bottle. The beam is angled outward and downward from the finish portion. The beam has a substantially vertical locking surface and a pushtab spaced along the beam. The angle of the beam is such that the pushtab may be depressed substantially radially toward the finish portion. The locking surface is located between the finish portion and the pushtab so that depression of the pushtab results in a greater beam deflection and lower deflection force at the pushtab than at the locking surface. A bottle closure has threads for rotatably securing the closure to the finish portion of the bottle. The closure also has a tooth projecting radially inward from its lower inner surface and so shaped and positioned that it will engage the locking surface of the resilient beam whenever there is an attempt to unscrew the closure. It thereby prevents removal of the closure until the pushtab is manually depressed to disengage the closure tooth from the locking surface of the cantilevered beam.
Patent NZ-302027-A (NZ)
Title: Thiazolium compounds and their use in pharmaceutical compositions
Inventor: CERAMI ANTHONY
IPC: C07D277/38
Filed: 1996-01-18
Abstract: Compositions and methods for inhibiting and reversing nonenzymatic cross-linking (protein aging) are described.  Accordingly, compositions are disclosed which comprise an agent capable of inhibiting the formation of advanced glycosylation end products of target proteins, and which additionally reverse pre-formed cross links in the advanced glycosylation end products by cleaving alpha-dicarbonyl-based protein cross links present in the advanced glycosylation end products. Certain agents useful are thiazolium salts. The method employs contacting the target protein with the composition. Both industrial and therapeutic applications for the composition are envisioned, for example food spoilage, animal protein aging and wrinkle reduction. An immunoassay for detection of the reversal of the nonenzymatic cross-linking is also disclosed. Useful agents include thiazolium compounds that have the structural formula (I) wherein RI and R2 are independently selected from the group consisting of hydrogen, hydroxy(lower)alkyl. acetoxy(lower)alkyl, lower alkyl, lower alkenyl, or Rl and R2 together with their ring carbons may be an aromatic fused ring, optionally substituted by one or more amino, halo or alkylenedioxy groups; Z is hydrogen or an amino group; Y is amino, a group of the formula -CH2C=OR wherein R is a lower alkyl, alkoxy, hydroxy, amino or an aryl group, said aryl group optionally substituted by one or more lower alkyl, lower alkoxy, halo, dialkylamino, hydroxy, nitro or alkylenedioxy groups; a group of the formula -CH2R' wherein R' is hydrogen, or a lower alkyl, lower alkynyl, or aryl group or a group of the formula CH2C=OR'NR''' wherein R" is hydrogen and R"' is a lower alkyl group, optionally substituted by an aryl group or an aryl group, said aryl group optionally substituted by one or more lower alkyl, halo, or alkoxylcarbonyl groups; or R" and R"' are both loweralkyl groups; X is a halide, tosylate, methanesulfonate or mesitylenesulfonate ion and mixtures thereof, and a carrier therefor. In this case the compounds of formula (I) are formed as biologically and pharmaceutically acceptable salts.  Useful salt forms are the halides, particularly the bromide and chloride, tosylate, methanesulfonate, and mesitylenesulfonate salts.  Other related salts can be formed using similarly non-toxic, and biologically and pharmaceutically acceptable anions. Of the compounds encompassed by formula (I), certain substituents are preferred. For instance, the compounds wherein Rl or R2 are lower alkyl groups are preferred.  Also highly preferred are the compounds wherein Y is an amino group, a 2-amino-2oxoethyl group, a 2-phenyl-2-oxoethyl or a 2-[substituted phenyl]-2-oxoethyl group. Representative compounds include: 3-aminothiazolium mesitylenesulfonate 3-(2-methoxy-2-oxoethyl)-thiazolium bromide 3-(2-methyl-2-oxoethyl)thiazolium chloride
Patent NZ-309614-A (NZ)
Title: Gamma electrolytic manganese dioxide treated with a lithium compound to produce an emd product containing lithium
Inventor: BOWDEN WILLIAM L
IPC: C01G45/00
Filed: 1996-06-05
Abstract: Disclosed is a process for treating manganese dioxide containing ion-exchangeable cations by replacing the ion-exchangeable cations present in the manganese dioxide with lithium by a process comprising first replacing ion-exchangeable cations present in the manganese dioxide with hydrogen. This readily is accomplished by slurrying the manganese dioxide in an aqueous acid solution. The resulting acidic manganese dioxide then is neutralized with a basic solution of a lithium containing compound, such as lithium hydroxide. This neutralization step serves to accomplish replacement of the previously introduced hydrogen, by ion-exchange, with lithium. The manganese dioxide then is washed with water, dried, and heat-treated at an elevated temperature, in conventional manner, to convert the gamma manganese dioxide to a mixture of the gamma and beta forms, which then is used as the active cathodic component in an electrochemical cell.
Patent NZ-329716-A (NZ)
Title: Sulfonamide substituted derivatives and medicaments thereof
Inventor: GERLACH DR UWE
IPC: A61K31/015
Filed: 1998-02-09
Abstract: isclosed are sulfonamide compounds of the formula (I).  The variables are as described in the specification. These compounds are particularly useful for the treatment of ulcers of the stomach caused by gastric acid secretion.
Patent NZ-333203-A (NZ)
Title: Tumour antigen proteins, genes thereof, and tumour antigen peptides
Inventor: ITOH KYOGO
IPC: A61K38/00
Filed: 1997-06-04
Abstract: These DNA's encode a protein having the amino acid sequence of SEQ ID NO: 1 or its modifications, provided that this protein and its modifications can form, through intracellular digestion, peptide fragments capable of binding to major histo-compatibility complex (MHC) class I antigens and being recognized by T cells in the bonded state; Also included are drugs containing these DNA's as the active ingredient; expression plasmids having these DNA's;  transformants transformed by these expression plasmids; and tumor antigen proteins and tumor antigen peptides produced by expressing these DNA's.
Patent NZ-501492-A (NZ)
Title: Di-amine and tetra-amine derivatives and pharmaceuticals thereof, useful for treating cardiac arrhythmia
Inventor: BERGERON RAYMOND J
IPC: A61P9/06
Filed: 1998-06-03
Abstract: The compounds of the formulae (I) and/or (II) are useful for the treatment of cardiac arrhythmia. R and R' may be the same or different and are H, alkyl, fluoroalkyl or aralkyl. R1 - R4 may be the same or different and are H, R or R'; m and n may be the same or different and are integers from 2 to 10; and x, y and z may be the same or different and are integers from 0 to 8.
Patent NZ-504605-A (NZ)
Title: Method and systems for bioremediating contaminated soil
Inventor: BOVA JOHN CARL
IPC: B09C1/06
Filed: 1998-10-15
Abstract: A system (1) and method for remediation of contaminated soil (15) removed from a soil site is provided.  The contaminated soil (15) is placed upon several layers of perforated heating pipes (14a, 14b, 14c) forming a remediation cell (10), and the entire cell (10) is covered by a galvanized Quonset Hut-shaped steel building (17) to prevent the escape of vapors from the soil cell (10).  Heating air introduced into perforated heating pipes (14a, 14b, 14c) conductively heats the contaminated soil (15) creating a differential pressure area around the heated pipes (14a, 14b, 14c).  This results in the migration of volatilized contaminates and moisture through the perforations in the pipe walls and into the lower pressure area within the heated steel pipes (14a, 14b, 14c), forcing the contaminants from the soil (15) and into an off-gas treatment system (19)
Patent NZ-506773-A (NZ)
Title: Process for making 1, 3-disubstituted-4-oxocyclic ureas
Inventor: MATSON PATRICIA ANN
IPC: A61K31/496
Filed: 1999-04-27
Abstract: A process for making 1,3-disubstituted-4-oxocyclic urea of formula (I) without isolation of intermediates and comprising the steps of (Ia) reacting a 1-substituted-4- oxocyclic urea with a carbon chain reagent containing at least two leaving groups in the presence of a mild base and a solvent to form an adduct containing at least one leaving group; and (Ib) condensing the adduct with an amine to form a 1,3-disubstituted-4-oxocyclic urea; and (II) recovering the 1,3-disubstituted-4-oxocyclic urea.
Patent NZ-507345-A (NZ)
Title: Medicinal compositions
Inventor: YAMANAKA MASAYUKI
IPC: A61K47/38
Filed: 1999-04-26
Abstract: A pharmaceutical composition comprising a macrolide compound, such as tricyclic compound or its salt, a dissolution/absorption promoter, a pharmaceutical base, a compatibilising agent and a thickener, where: the tricyclic compound is 17-allyl-1,14-dihydroxy-12-[2-(4-hydroxy-3-methoxycyclohexyl)-1-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa -4-azatricyclo[22.3.1.04,9]octacos-18-ene-2,3,10,16-tetraone or its hydrate; the dissolution/absorption promoter is diethyl sebacate; the pharmaceutical base is hydrophilic glycols; the compatibilising agent is diethylene glycol monoethyl ether; and the thickener is cellulose polymer or carboxyvinyl polymer The pharmaceutical composition comprising a macrolide compound is stable, has absorption kinetics properties and has a low irritation potential.
Patent NZ-509854-A (NZ)
Title: Age verification device
Inventor: FERRARO AMEDEO
IPC: G07F7/08
Filed: 1999-08-13
Abstract: An electronic age verification device that reads data stored on a data carrier or readable medium, such as a driver's license or identification card, then calculates and displays information such as the license or cardholder's age and the expiration status of the license or identification card.
Patent NZ-511324-A (NZ)
Title: Marine anchors having an embedment interacting with the anchor to pivot the fluke
Inventor: BRUCE PETER
IPC: B63B21/40
Filed: 1999-10-29
Abstract: A marine anchoring arrangement is described wherein a marine anchor (1, 23) is drivingly embedded vertically into a mooring bed (10) by an elongate follower (13), especially by its own weight and that of the follower. The follower (13) has a bottom clevis part (103) adapted to hold detachably the anchor (1) via the anchor shank (2) by means of a fulcrum pin (17) whereby the anchor (1) may swing relative to the bottom part (103). For initial penetration, the anchor (1) is held in a position of minimum forward resistance, specifically with the forward direction F of the fluke (3) parallel to the follower axis (20) and this is achieved by a shear pin (109) between the anchor (1) and the bottom part (103). When the anchor (1) is embedded to a preferred depth (d) specifically at least twice the square root of the maximum projected fluke area (as viewed normal to direction F), the anchor (23) is moved to a position for anchor setting by pulling on an attached anchor cable (4/4A) so causing the shear pin (109) to fracture and the anchor (23) to rotate about the fulcrum axis until arrested by a stop (21) on the follower (13). The follower (13) can then be pulled clear and recovered. The above anchoring arrangement provides a considerably improved anchoring performance in comparison with existing direct embedment arrangements.
Patent NZ-514671-A (NZ)
Title: Method for the preparation of citalopram
Inventor: PETERSEN HANS
IPC: C07D307/78
Filed: 1999-04-14
Abstract: A method of preparing citalopram of formula (I) comprises: a) subjecting a compound of formula IV to reductive hydrolysis and b) converting the resulting 5-formyl compound of formula V to the corresponding 5-cyano compound - citalopram which is isolated as the base or a pharmaceutically acceptable salt thereof. In formula IV R is R3-N(R2)-C(=O)- or an optionally substituted 4,5-dihydro-1,3-oxazol-2-yl and R1 and R2 are independently alkyl, aryl or heteroaryl or together form a 4 or 5-membered chain optionally comprising a S, O or N atom.
Patent NZ-516168-A (NZ)
Title: Self-righting inflatable life raft
Inventor: WIGGINS RENARD JONAS
IPC: B63B43/12
Filed: 2000-05-15
Abstract: A self-righting inflatable life raft (10) comprises  a raft  body (11) having inflatable side walls (21, 22) and  a floor  (15)  located therebetween. At least  two  inflatable tube  members form arches (51, 52) that extend from one side of  the  raft body to the other, each arch extends  upwardly and outwardly from a perimeter of said raft body (11) at  an angle  from  the perpendicular to said raft body.  The  life raft  has  a central axis of symmetry (61) and a  centre  of gravity  through which the weight of the life raft  acts  to rotate  the  raft on the surface of water from  an  unstable inverted  position  to a stable upright position.  The  tube members  when inflated have buoyancy sufficient to  exert  a turning  moment on the life raft (10) causing the life  raft to  topple  by gravity to an upright position. At least  one inflatable  interconnecting tube (70, 71,  72,  76,  77)  is positioned between the arches (51, 52) and offset  from  the central axis (61) to increase the turning moment.
Patent NZ-518688-A (NZ)
Title: Storage-stable aerated gel composition and a process for producing it
Inventor: TWYDELL ROLAND
IPC: C08L31/00
Filed: 2000-11-15
Abstract: A storage-stable aerated gel composition comprising 30 to 97% by weight of water, 0.2 to 5% by weight of a gelling agent selected from xanthan gum, sodium alginate and neutralized carboxyvinyl polymer, and 2 to 5% by weight of a fine particulate, hydrophobic silicone-treated silica having a surface area of from 80 to 300 m2/g. The composition is in the form of fine particles of an aqueous gel containing the water and gelling agent, the surfaces of the particles are coated with the finely particulate hydrophobic silica.
Patent NZ-518766-A (NZ)
Title: Adjuvanted genetic vaccines
Inventor: HAYNES JOEL R
IPC: A61K48/00
Filed: 1999-11-03
Abstract: Coated particles for inducing an enhanced immune response suited for use in particle-mediated nucleic acid immunisation comprise core carrier particles coated with a nucleic acid molecule comprising a sequence encoding an antigen, and adjuvant which is effective to enhance at least one component of an immune response elicited against the antigen, wherein the adjuvant is present in a form other than DNA. Preferably the antigen is from a viral, bacteria, parasite or fungal pathogen such as HBV, HIV, influenza virus, circumsporozoite antigen from malarial parasite, or a tumor specific or autoimmune associated antigen, the adjuvant is a saponin, monophosphoryl lipid A, or a protein derived from BCG, and the core particles are tungsten or gold particles.
Patent NZ-519477-A (NZ)
Title: Attenuated microorganisms for the treatment of infection
Inventor: DOUGAN GORDON
IPC: A61P31/04
Filed: 2000-11-10
Abstract: An isolated Salmonella microorganism having an attenuating microorganism that disrupts that expression of an aro gene and the sifA gene; the use of said microorganism for treating systemic bacterial infection.